Weiss Multi-Strategy Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$149K	–	733
2019 Q2	$149K	Sell	10,000 -15,000	-60%	-$271K	﹤0.01%	475
2019 Q1	$621K	Buy	+25,000	New	+$627K	0.02%	424
2015 Q2	–	Sell	-5,000	Closed	-$371K	–	552
2015 Q1	$371K	Sell	5,000 -5,000	-50%	-$353K	0.02%	386
2014 Q4	$560K	Sell	10,000 -5,000	-33%	-$263K	0.02%	332
2014 Q3	$680K	Buy	+15,000	New	+$627K	0.02%	419

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CLVS Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of Clovis Oncology, Inc. (CLVS) in Q4 2020, closing a stake of 66,000 shares — an estimated $385K sold.

Weiss Multi-Strategy Advisers first reported a position in CLVS in Q1 2017 and held it in 15 quarters. The position peaked at $2.47M in Q3 2017. 159 funds tracked by Wall St. Rank hold CLVS as of Q4 2020.

Weiss Multi-Strategy Advisers reported no remaining Clovis Oncology, Inc. position as of Q4 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 66,000 Clovis Oncology, Inc. shares in Q4 2020, an estimated $385K.
Weiss Multi-Strategy Advisers first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 15 quarters.
Weiss Multi-Strategy Advisers's Clovis Oncology, Inc. position peaked at $2.47M in Q3 2017.
159 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.